Coronary Stents Market for BMS and DES Worth $5.61 Billion by 2020

DALLAS, November 26, 2014 /PRNewswire/ --

 The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bio absorbable stents can be used to treat coronary artery disease, and optimize outcomes.

RnRMarketResearch.com adds 3 coronary stents market research reports published in November 2014 and titled Coronary Stents - Current and Future Players, Coronary Stents - EU Analysis and Market Forecasts and Coronary Stents - US Analysis and Market Forecasts to the medical devices industry intelligence collection of its library.

The Coronary Stents - Current and Future Players report says this industry is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation.

Profiles of companies like Abbott Vascular, Boston Scientific Corporation, Medtronic, Alvimedica, Amaranth Medical, AMG International, Arterial Remodeling Technologies, B. Braun, Balton, Biosensors International, Biotronik, Blue Medical, Cardionovum, C.R. Bard, Elixir Medical Corporation, eucatech AG, Hexacath, IRAMED, JW Medical Systems, Kyoto Medical Planning, Lepu Medical Technology, MicroPort Scientific Corporation, Minvasys, MIV Therapeutics, Opto Circuits, OrbusNeich Medical, Relisys Medical Devices, REVA Medical, Sahajanand Medical Technologies, STENTYS, Terumo Corporation, Translumina, Vascular Concepts and Other Companies are covered in this research available for purchase at http://www.rnrmarketresearch.com/contacts/purchase?rname=244875 .

Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. Among the different types of stents available, DES dominate the market. As BAS enter the US, Japanese, and Chinese markets, and their designs are improved, the next generation of DES with biodegradable polymer/polymer-free coatings are adopted, long-term clinical data become available, and appropriate reimbursement rates are established, the Coronary Stents - US Analysis and Market Forecasts report believes that the coronary stent market will increase in the future. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Complete research is available at http://www.rnrmarketresearch.com/coronary-stents-us-analysis-and-market-forecasts-market-report.html .

This report helps understand the trends shaping and driving the US Coronary Stents market. Realize device preferences of physicians who have performed the tests already, access market sizing, forecasts and quantified growth opportunities in the US Coronary Stents market through 2018, quantify candidate patient populations to better design product pricing & launch plans and see how to drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. This research also helps perform benchmarking analysis of growth opportunities against currently marketed products, assess competitiveness of products in market by understanding the strengths and weaknesses of current competition, take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products, create an effective counter-strategy to gain a competitive advantage against those currently in the market and organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. What's the next big thing in the US Coronary Stents market landscape? Identify, understand and capitalize. Order a copy of Coronary Stents - US Analysis and Market Forecasts report at http://www.rnrmarketresearch.com/contacts/purchase?rname=244877 .

The coronary stents market in the EU has an overall negative CAGR of 0.5% over the forecast period from 2011-2020. Similar to the US, the DES market in the EU has the largest share, where the DES market is four times that of the BMS market. Moving forward, GlobalData believes that the DES market will grow slowly due to the improved outcomes, the development of low-profile systems and the next generation of DES, and cost-savings due to the reduced need for repeat intervention.

According to Coronary Stents - EU Analysis and Market Forecasts report (http://www.rnrmarketresearch.com/coronary-stents-eu-analysis-and-market-forecasts-market-report.html ), in the EU, there is a strong dependency on reimbursement, which can vary between nations. German reimbursement has generally been strong for medical devices, and has been less of a problem. However, the other countries are keen to follow clinical outcomes carefully for adoption and product usage in order to obtain reimbursement.

Coronary stents market drivers like Rising Prevalence of Disease, Viable Treatment for Challenging Coronary Indications, Innovations in Stent Technology, Development of Bioabsorbable Stents, Reduce the Need for Prolonged Dual Antiplatelet Therapy, Potential Cost Savings, Use of Imaging Modalities for Accurate Stent Placement, Adoption of Stents in the Emerging Markets and Launch of Bioabsorbable Stents in US and Japan are discussed in this research. Industry barriers covered include Concerns Regarding Overstenting, Post-ProceduraI Complications of Drug-Eluting Stenting, Risk of Perioperative Adverse Cardiac Events Post-Stenting, Slow Adoption of Bioabsorbable Stents, Lack of Reimbursement, Healthcare Cost-Cutting and Reimbursement, Availability of Venture Capital and Medical Device Excise Tax. Drug-eluting balloons and liquid drug delivery catheter are the substitutes to coronary stents reviewed in this EU research available for purchase at http://www.rnrmarketresearch.com/contacts/purchase?rname=244876 .

Explore more reports on medical devices industry at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .

About Us: 

RnRMarketResearch.com is an online database of market research reports and in-depth studies of over 5000 micro markets. Not limited to any one industry, we offer research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:  

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441
sales@rnrmarketresearch.com